WALTHAM, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enablingindividuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the UBS 20th Annual Global Healthcare Services Conference being held February
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.
SOURCE Inverness Medical Innovations, Inc.
Subscribe to our Free Newsletters!